The FDA initially approved the drug in 2014 as ... with heart failure across the spectrum of ejection fraction," said Javed Butler, M.D, chairman, Department of Medicine, University of Mississippi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback